Literature DB >> 23162039

Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium.

Miguel A Materin1, Gregory A Kuzmik, Paul T Jubinsky, Frank J Minja, Jeremy D Asnes, Ketan R Bulsara.   

Abstract

We present a description of retinoblastoma treated with supraselective intra-arterial chemotherapy, demonstrating selective delivery of the infused chemotherapeutic agent into the tumor bed by MRI. A 7-month-old presented with group E (international classification) unilateral retinoblastoma. We treated the patient with several rounds of intra-ophthalmic artery melphalan. Gadolinium was infused along with melphalan to visualize the distribution of this chemotherapeutic drug. Intraoperative MRI was obtained within 15 min after treatment and showed increased enhancement of the tumor and subretinal space. We demonstrate here that supraselective administration of chemotherapy into the ophthalmic artery appears to result in drug delivery to the tumor and subretinal space.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23162039      PMCID: PMC4545047          DOI: 10.1136/bcr-2012-010508

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.

Authors:  Carol L Shields; Carlos G Bianciotto; Pascal Jabbour; Aparna Ramasubramanian; Sara E Lally; Gregory C Griffin; Robert Rosenwasser; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2011-06-13

2.  Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.

Authors:  Eric C Peterson; Mohamed Samy Elhammady; Stacey Quintero-Wolfe; Timothy G Murray; Mohammad Ali Aziz-Sultan
Journal:  J Neurosurg       Date:  2011-02-04       Impact factor: 5.115

3.  Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.

Authors:  Y Pierre Gobin; Ira J Dunkel; Brian P Marr; Scott E Brodie; David H Abramson
Journal:  Arch Ophthalmol       Date:  2011-02-14

4.  A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Authors:  David H Abramson; Ira J Dunkel; Scott E Brodie; Jonathan W Kim; Y Pierre Gobin
Journal:  Ophthalmology       Date:  2008-03-14       Impact factor: 12.079

5.  The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.

Authors:  Takashi Yamane; Akihiro Kaneko; Makoto Mohri
Journal:  Int J Clin Oncol       Date:  2004-04       Impact factor: 3.402

6.  Use of gadolinium as an intraarterial contrast agent for pediatric neuroendovascular procedures.

Authors:  Matthew V Burry; Jeffrey Cohen; Robert A Mericle
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

  6 in total
  1 in total

Review 1.  Retinoblastoma, the visible CNS tumor: A review.

Authors:  Helen Dimaras; Timothy W Corson
Journal:  J Neurosci Res       Date:  2018-01-03       Impact factor: 4.164

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.